1-9 of 9
Stephen Daw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with High-Risk Classic Hodgkin Lymphoma (cHL) with Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Luciana Vinti, Stephen Daw, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Lorena Valero-Arrese, Franca Fagioli, Stéphane Ducassou, Salvatore Buffardi, Thierry Leblanc, Bradford S Hoppe, Frank G. Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Rushdia Yusuf, Auke Beishuizen
Journal: Blood
Blood (2024) 144 (Supplement 1): 3055.
https://doi.org/10.1182/blood-2024-199675
Published: 2024
Journal Articles

Circulating Tumor DNA (ctDNA) Assessment in Pediatric Patients with Newly Diagnosed High-Risk Classic Hodgkin Lymphoma (cHL): Exploratory Analysis from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Luciana Vinti, Gerard Michel, Auke Beishuizen, Franca Fagioli, Lorena Valero-Arrese, Salvatore Buffardi, Michaela Cepelova, Stephen Daw, Antony Ceraulo, Thierry Leblanc, Anne Thorwarth, Charlotte Rigaud, Theresa Jox, Maximilian Dörrbecker, Stefan Gattenlöhner, Marek Bartkuhn, Mackenzie Edmondson, Yuehui Zhao, Haitao Li, Pallavi Pillai, Razvan Cristescu, Carol Peña, Andreas Bräuninger
Journal: Blood
Blood (2024) 144 (Supplement 1): 6196.
https://doi.org/10.1182/blood-2024-200309
Published: 2024
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Auke Beishuizen, Luciana Vinti, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Franca Fagioli, Constantino Sabado Alvarez, Stephane Ducassou, Salvatore Buffardi, Maitane Andión Catalan, Brad Hoppe, Frank Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Stephen Daw
Journal: Blood
Blood (2023) 142 (Supplement 1): 3063.
https://doi.org/10.1182/blood-2023-187028
Published: 2023
Journal Articles

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults

Clinical Trials & Observations
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, Maurizio Mascarin, Gérard Michel, Stacy Cooper, Auke Beishuizen, Kasey J. Leger, Loredana Amoroso, Salvatore Buffardi, Charlotte Rigaud, Bradford S. Hoppe, Julie Lisano, Stephen Francis, Mariana Sacchi, Peter D. Cole, Richard A. Drachtman, Kara M. Kelly, Stephen Daw
Journal: Blood
Blood (2023) 141 (17): 2075–2084.
https://doi.org/10.1182/blood.2022017118
Published: 2023
Includes: Supplemental data
Journal Articles

Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma

Paul Harker-Murray, MD PhD, Thierry Leblanc, MD, Maurizio Mascarin, Christine Mauz-Körholz, Gerard Michel, MD, Stacy Cooper, MD, Auke Beishuizen, MD PhD, Kasey J. Leger, MD MSc, Alberto Garaventa, Salvatore Buffardi, MD, Laurence Brugieres, MD, Kara M. Kelly, MD, Peter D. Cole, MD, Richard A. Drachtman, Faith Galderisi, DO, Mariana Sacchi, MD, Ying-Ming Jou, Stephen Daw
Journal: Blood
Blood (2018) 132 (Supplement 1): 927.
https://doi.org/10.1182/blood-2018-99-111279
Published: 2018
Journal Articles

The Incidence of Invasive Fungal Infections in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukaemia/Lymphoma Treated with the UKALL2011 Protocol: a Multicentre Retrospective Study

Maeve A O'Reilly, MB, Dinisha Govender, Ajay Vora, MD, Sujith Samarasinghe, Asim Khwaja, Victoria Grandage, Anupama Rao, Phil Ancliff, Danny Cheng, Ben Carpenter, Stephen Daw, David O'Connor, Rachael Hough, MD BMBS, FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 102.
https://doi.org/10.1182/blood.V130.Suppl_1.102.102
Published: 2017
Journal Articles

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

Franco Locatelli, MD, Kathleen A Neville, MD, MS, Angelo Rosolen, MD, Judith Landman-Parker, MD, Nathalie Aladjidi, MD, Auke Beishuizen, MD, Stephen Daw, BSc Hons, MBChB, MRCP, Lia Gore, MD, Anna R.K. Franklin, MD, Adedigbo Fasanmade, PhD, Jingyuan Wang, PhD, Jessica Sachs, MD, Christine Mauz-Koerholz, MD
Journal: Blood
Blood (2013) 122 (21): 4378.
https://doi.org/10.1182/blood.V122.21.4378.4378
Published: 2013
Journal Articles

Cerebral Venous Thrombosis in Adolescents and Young Adults with Classical Hodgkin Lymphoma

Poornima Kumar, MBBS, Rebekah Ahmed, MBBS, Renu Riat, MBBS, Kirit M Ardeshna, MD, Stephen Daw, MBChb
Journal: Blood
Blood (2012) 120 (21): 4784.
https://doi.org/10.1182/blood.V120.21.4784.4784
Published: 2012
Journal Articles

Treatment of Children & Adolescents with Early Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma with a Low Intensity Short Duration Chemotherapy Regimen [CVP] - on Behalf of the EuroNet-PHL Group.

Ananth G. Shankar, Stephen Daw, Georgina Hall, Stephanie Gorde-Grosjean, Christine Mauz Koerholz, Dieter Korholz, William H. Wallace, Dirk Hasenclever, Judith Landman-Parker
Journal: Blood
Blood (2006) 108 (11): 2471.
https://doi.org/10.1182/blood.V108.11.2471.2471
Published: 2006